Literature DB >> 510000

Determination of bronchodilation in the clinical pulmonary function laboratory. Role of changes in static lung volumes.

J W Ramsdell, G M Tisi.   

Abstract

Improved airway resistance following bronchodilator inhalation is not always accompanied by improvement in forced expiratory flow. We studied 241 patients with airways obstruction to learn whether changes in static lung volumes (vital capacity and function residual capacity measured by body plethysmography [FRCB]) would reveal bronchodilation not demonstrated by expiratory flow rates (the ratio of forced vital capacity at one second to the total forced vital capacity [FEV1/FVC]), and the forced expiratory flow for the midportion of the forced vital capacity (FEF25--75%). A significant fall in Raw occurred in 129 patients, 46 of whom had a significant increase in vital capacity (mean of + 465 ml +/- 43, P less than 0.001) and a fall in FRCB (mean of -763 ml +/- 78 P less than 0.001) with no change in FEV1/FVC% of FEF25--75%. We interpret these data to indicate that improvement in static lung volumes can reflect bronchodilation in the absence of improved expiratory flow.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 510000     DOI: 10.1378/chest.76.6.622

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Authors:  D M Newnham; D P Dhillon; J H Winter; C M Jackson; R A Clark; B J Lipworth
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

Review 2.  Using pulmonary function testing in the diagnosis and treatment of asthma.

Authors:  A D Siefkin
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

3.  Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.

Authors:  P A Corris; E Neville; S Nariman; G J Gibson
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

4.  Lessons from the World Trade Center disaster: airway disease presenting as restrictive dysfunction.

Authors:  Kenneth I Berger; Joan Reibman; Beno W Oppenheimer; Ioannis Vlahos; Denise Harrison; Roberta M Goldring
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

5.  Dose response relation to oral theophylline in severe chronic obstructive airways disease.

Authors:  H Chrystyn; B A Mulley; M D Peake
Journal:  BMJ       Date:  1988-12-10

6.  Bronchodilator Response Predicts Longitudinal Improvement in Small Airway Function in World Trade Center Dust Exposed Community Members.

Authors:  Deepak Pradhan; Ning Xu; Joan Reibman; Roberta M Goldring; Yongzhao Shao; Mengling Liu; Kenneth I Berger
Journal:  Int J Environ Res Public Health       Date:  2019-04-20       Impact factor: 3.390

7.  Bronchodilator responsiveness and reported respiratory symptoms in an adult population.

Authors:  Wan C Tan; Jean Bourbeau; Paul Hernandez; Kenneth R Chapman; Robert Cowie; J Mark FitzGerald; Shawn Aaron; Darcy D Marciniuk; Francois Maltais; A Sonia Buist; Denis E O'Donnell; Don D Sin
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

8.  Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general population.

Authors:  Annette Kainu; Ari Lindqvist; Seppo Sarna; Bo Lundbäck; Anssi Sovijärvi
Journal:  Respir Res       Date:  2009-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.